In recent years, profiling the impurities of an active pharmaceutical ingredient and finished medicinal product has become increasingly important and is now a major issue that can prevent the granting of a marketing authorisation or the certification of EP suitability. DADA is specialized in evaluating impurity profiles and has successfully helped many companies solve problems related to the impurity profile of their active pharmaceutical ingredient or finished medicinal product.